CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale SVP Clinical, Med. & Reg.; CMO sold 12,376 shares at an average $5.51 ($68,159)
- 4 Open-market sale President, CEO and CFO sold 13,283 shares at $5.76 ($76,458)
- 4 Open-market sale SVP Strategic Plan. & Bus. Ops sold 6,300 shares at $5.80 ($36,530)
- 4 Open-market sale SVP Clinical, Med. & Reg.; CMO sold 8,596 shares at $5.76 ($49,479)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 4,900 shares at $5.87 ($28,763)
- 4 Open-market sale Director sold 3,400 shares at an average $5.83 ($19,828)
- 4 Open-market sale Director sold 24,700 shares at an average $5.76 ($142,171)
- 4 Open-market sale President, CEO and CFO sold 3,181 shares at $5.65 ($17,973)
- 4 Open-market sale SVP Clinical, Med. & Reg.; CMO sold 2,985 shares at $5.65 ($16,869)
- 4 Open-market sale Director sold 15,093 shares at $5.74 ($86,634)
- 4/A Open-market sale Director sold 1,907 shares at $5.74 ($10,946)
- 4 Open-market sale Director sold 1,907 shares at $5.74 ($10,946)
- 4 Open-market sale Director sold 4,705 shares at $5.49 ($25,830)
- 4 Open-market sale Director sold 6,700 shares at $5.53 ($37,051)
- 4 Open-market sale Director sold 8,195 shares at an average $5.24 ($42,975)
- 4 Open-market sale Director sold 4,900 shares at $5.30 ($25,970)
- 4 Open-market sale Director sold 17,600 shares at an average $5.35 ($94,078)
Page 16 of 28 · 550 filings